Intellia Therapeutics, Inc.
NTLA · In Vitro & In Vivo Diagnostic Substances · 139.7M shares · +17%/yr ↑ dilution · EDGAR filings ↗
Reference price $13.78 · est. market cap ~$1.9B — last insider sale, 2026-03-02 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical/early-stage biotech — in-vivo CRISPR clinical, heavy burn ($396M), very well-funded.
Strengths
- Liquidity — current ratio 5.1 (93rd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Chronic dilutionShare count +17%/yr over 3y (dilution, book value/share -66%)
- Cash burnNegative free cash flow (-395.9M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, Bridgewater Associates, LP, RENAISSANCE TECHNOLOGIES LLC
- Net lossNet loss (net margin -609.9%)
- Insider buyingInsider buying — 1 open-market buy(s) by 1 insider(s) (~$1M, last 6mo) Form 4 ↗
- Insider sellingInsider selling — 9 open-market sale(s) by 7 insider(s) (cluster of 7 insiders, ~$797,191, last 6mo) Form 4 ↗
- Revenue declineRevenue -34.6% YoY
- Notable holderHeld by 5 notable fund(s): ARK Investment Management LLC, STATE STREET CORP, FMR LLC +2 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-651.7%
Net margin
-609.9%
Return on equity
-61.5%
Return on assets
-49.0%
Revenue growth (QoQ)
-34.6%
Current ratio
5.1×
Free cash flow
-$396M
EBITDA
-$431M
Tangible book value
$671M
Cash & investments
$605M
Cash runway
6q
Stock comp / revenue
118.5%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-09 | Verwiel Frank | Grant | 9.2K | — |
| 2026-06-09 | Keresty Georgia | Grant | 9.2K | — |
| 2026-06-09 | Goff Brian | Grant | 9.2K | — |
| 2026-06-09 | Cohen Fred E | Grant | 9.2K | — |
| 2026-06-09 | Bhanji Muna | Grant | 9.2K | — |
| 2026-06-09 | CHASE WILLIAM J | Grant | 9.2K | — |
| 2026-06-09 | GOODMAN JESSE | Grant | 9.2K | — |
| 2026-03-02 | Clark Eliana | Sell | 607 | $13.78 |
| 2026-03-02 | BASTA JAMES | Sell | 1.2K | $13.78 |
| 2026-03-01 | Dube Michael P | Grant | 17K | — |
| 2026-03-01 | LEONARD JOHN M | Grant | 156K | — |
| 2026-03-01 | BASTA JAMES | Grant | 46K | — |
| 2026-03-01 | Lebwohl David | Grant | 9.9K | — |
| 2026-03-01 | Dulac Edward J III | Grant | 61K | — |
| 2026-03-01 | Schultes Birgit C | Grant | 39K | — |
| 2026-03-01 | Clark Eliana | Grant | 7.4K | — |
| 2026-01-05 | Schultes Birgit C | Sell | 8.5K | $9.21 |
| 2026-01-05 | LEONARD JOHN M | Sell | 34K | $9.21 |
| 2026-01-05 | BASTA JAMES | Sell | 10K | $9.21 |
| 2026-01-05 | Cohen Fred E | Buy | 150K | $9.35 |
| 2026-01-05 | Lebwohl David | Sell | 12K | $9.21 |
| 2026-01-05 | Clark Eliana | Sell | 9.5K | $9.21 |
| 2026-01-05 | Dulac Edward J III | Sell | 6.4K | $9.21 |
| 2026-01-05 | Dube Michael P | Sell | 3.0K | $9.21 |
| 2025-12-12 | LEONARD JOHN M | Option exercise | 8.6K | $6.83 |
| 2025-12-11 | LEONARD JOHN M | Option exercise | 50K | $6.83 |
| 2025-12-11 | LEONARD JOHN M | Sell | 50K | $9.49 |
| 2025-12-11 | LEONARD JOHN M | Sell | 33K | $9.47 |
| 2025-12-11 | LEONARD JOHN M | Sell | 5.4K | $9.59 |
| 2025-10-01 | Schultes Birgit C | Sell | 31 | $17.38 |
| 2025-10-01 | Dube Michael P | Sell | 1.9K | $17.38 |
| 2025-08-20 | CHASE WILLIAM J | Buy | 100K | $10.03 |
| 2025-07-23 | Dulac Edward J III | Sell | 7.5K | $14.02 |
| 2025-07-02 | Dube Michael P | Sell | 2.5K | $9.95 |
| 2025-07-01 | Clark Eliana | Sell | 1.0K | $9.82 |
| 2025-07-01 | GOODMAN JESSE | Sell | 1.5K | $9.23 |
| 2025-06-30 | GOODMAN JESSE | Sell | 1.5K | $9.56 |
| 2025-06-11 | GOODMAN JESSE | Grant | 8.0K | — |
| 2025-06-11 | Goff Brian | Grant | 8.0K | — |
| 2025-06-11 | Bhanji Muna | Grant | 8.0K | — |
| 2025-06-11 | CHASE WILLIAM J | Grant | 8.0K | — |
| 2025-06-11 | Verwiel Frank | Grant | 8.0K | — |
| 2025-06-11 | Cohen Fred E | Grant | 8.0K | — |
| 2025-06-11 | Keresty Georgia | Grant | 8.0K | — |
| 2025-04-29 | Bhanji Muna | Sell | 265 | $8.50 |
| 2025-03-04 | BASTA JAMES | Sell | 2.6K | $8.99 |
| 2025-03-04 | Clark Eliana | Sell | 679 | $8.99 |
| 2025-03-01 | Schultes Birgit C | Grant | 38K | — |
| 2025-03-01 | Clark Eliana | Grant | 32K | — |
| 2025-03-01 | LEONARD JOHN M | Grant | 136K | — |
| 2025-03-01 | Dulac Edward J III | Grant | 47K | — |
| 2025-03-01 | Dube Michael P | Grant | 14K | — |
| 2025-03-01 | Lebwohl David | Grant | 43K | — |
| 2025-03-01 | BASTA JAMES | Grant | 40K | — |
| 2025-01-29 | Bhanji Muna | Sell | 265 | $9.97 |
| 2025-01-03 | Dube Michael P | Sell | 1.4K | $12.18 |
| 2025-01-03 | BASTA JAMES | Sell | 7.1K | $12.18 |
| 2025-01-03 | Lebwohl David | Sell | 9.6K | $12.18 |
| 2025-01-03 | Hicks Derek | Sell | 6.5K | $12.18 |
| 2025-01-03 | LEONARD JOHN M | Sell | 27K | $12.18 |
| 2025-01-03 | Sepp-Lorenzino Laura | Sell | 9.0K | $12.18 |
| 2025-01-03 | Clark Eliana | Sell | 7.4K | $12.18 |
| 2025-01-02 | Clark Eliana | Sell | 556 | $12.03 |
| 2025-01-01 | Sepp-Lorenzino Laura | Option exercise | 3.5K | — |
| 2025-01-01 | Lebwohl David | Option exercise | 3.2K | — |
| 2025-01-01 | LEONARD JOHN M | Option exercise | 7.8K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-15 | Reg FDOtherExhibits | filing ↗ |
| 2026-06-10 | Shareholder vote | filing ↗ |
| 2026-05-11 | ResultsExhibits | filing ↗ |
| 2026-04-30 | Material agreementResultsExhibits | filing ↗ |
| 2026-04-27 | Reg FDOtherExhibits | filing ↗ |
| 2026-04-10 | 5.03Exhibits | filing ↗ |
| 2026-03-02 | Material agreementReg FDOtherExhibits | filing ↗ |
| 2026-02-26 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-15 | 2026-06-13 | 0001193125-26-270358 ↗ |
| 8-K | 2026-06-10 | 2026-06-09 | 0001193125-26-265934 ↗ |
| 8-K | 2026-05-11 | 2026-05-11 | 0001193125-26-215721 ↗ |
| 10-Q | 2026-05-11 | 2026-03-31 | 0001193125-26-215740 ↗ |
| 8-K | 2026-04-30 | 2026-04-27 | 0001193125-26-197489 ↗ |
| 8-K | 2026-04-27 | 2026-04-27 | 0001193125-26-179401 ↗ |
| 8-K | 2026-04-10 | 2026-04-07 | 0001193125-26-151300 ↗ |
| 8-K | 2026-03-02 | 2026-03-02 | 0001193125-26-084309 ↗ |
| 8-K | 2026-02-26 | 2026-02-26 | 0001193125-26-073456 ↗ |
| 10-K | 2026-02-26 | 2025-12-31 | 0001193125-26-076550 ↗ |
| 8-K | 2026-01-27 | 2026-01-27 | 0001193125-26-023387 ↗ |
| 8-K | 2026-01-09 | 2026-01-09 | 0001193125-26-008307 ↗ |